BRIEF published on 03/07/2025 at 16:26, 1 month 1 day ago CLINUVEL Pharmaceuticals Sees Record Growth in H1/FY25 Investment Strategy Market Expansion Record Growth CLINUVEL Pharmaceuticals Clinical Projects
BRIEF published on 03/07/2025 at 16:26, 1 month 1 day ago CLINUVEL Pharmaceuticals enregistre une croissance record au premier semestre de l'exercice 2025 Stratégie D'investissement Croissance Record Expansion Du Marché Produits Pharmaceutiques CLINUVEL Projets Cliniques
PRESS RELEASE published on 03/07/2025 at 16:21, 1 month 1 day ago Original-Research: CLINUVEL Pharmaceuticals (von Parmantier & Cie. GmbH): BUY CLINUVEL Pharmaceuticals demonstrates impressive H1/FY25 results, increasing revenue and EPS. New strategy focuses on vitiligo treatment, leading in science-based cosmetic products Investment Recommendation CLINUVEL Pharmaceuticals H1/FY25 Results Vitiligo Treatment Cosmetic Products
Published on 04/09/2025 at 09:00, 1 hour 5 minutes ago Touchstone Exploration Announces Changes to Its Board of Directors
Published on 04/09/2025 at 08:00, 2 hours 5 minutes ago Ondine Biomedical Inc. - Economic Study Suggests c.£200 Million UK Savings
Published on 04/09/2025 at 07:40, 2 hours 25 minutes ago RTG Mining Inc. Announces Issue Of A$4.2 million Chess Depository Instruments Under Placement
Published on 04/09/2025 at 04:00, 6 hours 5 minutes ago QNX Now Powering WeRide's Next-Generation ADAS Platform
Published on 04/08/2025 at 22:47, 11 hours 18 minutes ago MicroVision Announces Retail Investor Day in Redmond, WA on May 20, 2025
Published on 04/09/2025 at 09:37, 27 minutes ago Partec AG: ParTec AG announces major participation in advancing Europe’s Digital Autonomy in HPC and AI with the DARE SGA1 Project
Published on 04/09/2025 at 09:24, 41 minutes ago H&R GmbH & Co. KGaA publishes Annual Report and Sustainability Report for FY 2024
Published on 04/09/2025 at 09:06, 58 minutes ago EQS-Adhoc: swissnet Group announces delisting of its shares from Euronext Access+ Paris
Published on 04/09/2025 at 09:05, 1 hour ago More Impact AG introduces Z-Boxx as an innovative smoking cessation product
Published on 04/09/2025 at 09:00, 1 hour 5 minutes ago Original-Research: Multitude SE (von NuWays AG): BUY
Published on 04/09/2025 at 09:00, 1 hour 5 minutes ago STEF : Avis de mise à disposition des comptes annuels 2024
Published on 04/09/2025 at 08:00, 2 hours 5 minutes ago Museum Studio becomes a majority shareholder in Lord Cultural Resources
Published on 04/09/2025 at 08:00, 2 hours 5 minutes ago Museum Studio devient actionnaire majoritaire de Lord Cultural Resources
Published on 04/09/2025 at 07:00, 3 hours 5 minutes ago Biophytis confirme le lancement de l’essai clinique de Phase 2 OBA dans l’obésité
Published on 04/09/2025 at 07:00, 3 hours 5 minutes ago Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity
